Targeting human telomerase for cancer therapeutics. - Wikidata - awgldk - TriplyDB

Targeting human telomerase for cancer therapeutics.

Targeting human telomerase for cancer therapeutics.

http://www.wikidata.org/entity/Q33383955

about

Preferential binding of a G-quadruplex ligand to human chromosome ends.G-quadruplexes as potential therapeutic targets for embryonal tumors.Development of anticancer drugs based on the hallmarks of tumor cells.RNA interference mediated downregulation of human telomerase reverse transcriptase (hTERT) in LN18 cells.

P2860

Q24815673-F6D57488-4485-4FB3-BD08-451C5BE192CC Q38154988-8965DC33-A5B6-4EC8-9A27-830A1526EA3E Q38182491-5EB20D11-F64E-486A-AE47-7509BA663403 Q38739741-F85628B4-7944-4CEB-8DAD-777E432B74A1

P2860

Targeting human telomerase for cancer therapeutics.

http://www.wikidata.org/entity/Q33383955

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Targeting human telomerase for cancer therapeutics.

@ast

Targeting human telomerase for cancer therapeutics.

@en

type

label

Targeting human telomerase for cancer therapeutics.

@ast

Targeting human telomerase for cancer therapeutics.

@en

prefLabel

Targeting human telomerase for cancer therapeutics.

@ast

Targeting human telomerase for cancer therapeutics.

@en

P1433

Q33383955-E6EB3EC0-215B-49E7-80AF-1F501F49BBAF

P1476

Q33383955-797C55AC-519A-4655-8543-DE84EED03087

P2093

Q33383955-077BEEBC-1ABC-4651-92A6-172662FF1715

Q33383955-15E807F8-DB46-4A5B-A945-F953EB3DD545

Q33383955-3D4055E3-C048-403A-83F1-D93016524C53

Q33383955-4329A544-3F6E-49D5-A7A6-55CC7810D1EB

Q33383955-835202A2-CA20-48DD-AF5A-ED9519991244

Q33383955-A08B6852-E9A2-43AE-AE12-59C57D393083

Q33383955-A9DE1D36-F0C6-442E-ACA1-FF8E1014519D

Q33383955-D2298726-012C-4ACD-B546-778DD0117C9E

Q33383955-FDBE14DC-2946-4DC2-A14B-E0D9BAB75102

P2860

Q33383955-08493E6E-BF42-4C54-ACF9-CED0CCB29E41

Q33383955-09B58A39-0723-4D8C-847B-240C9D11C9E8

Q33383955-0B660208-F449-4FB8-868E-7167165129BE

Q33383955-0CAA219A-630F-4E29-BA40-F4B2B3DBD829

Q33383955-0DE0A120-C9A0-42A3-804A-D31C560EEE06

Q33383955-1030A0A3-B245-4114-A818-995D5ED913D7

Q33383955-11237DB5-D2C8-49B7-9760-A1DB29862087

Q33383955-14DA12EF-D5AD-4280-B2E0-F4E0057D82FE

Q33383955-1B4C81BD-2811-4D51-9BE4-EB0AF44D6F13

Q33383955-1F33EA44-35B9-40F9-A05D-54456D8C6809

P2888

Q33383955-181A51E8-AB9C-407B-805F-107E56242924

P304

Q33383955-198D7F05-8786-4E7B-8330-02169F9A3C8B

P31

Q33383955-C442ED0A-F9E7-4CA0-B64F-CB7705FE0CD3

P356

Q33383955-2DD73B42-AA87-429C-923B-C15795421D37

P433

Q33383955-0EEF4692-2618-4514-96DA-12C743AAF316

P478

Q33383955-D1913449-F91A-4668-83E5-DF6FA8DE410B

P50

Q33383955-0F4F6CBC-359F-49DF-A700-A3D8BEFF894A

Q33383955-1FCADBB0-C7CF-410A-9D77-D90E3C4A0EA5

Q33383955-39FDBC74-1399-4CD4-9BAB-8F8C382F2167

Q33383955-5AFFB60D-AB7C-4724-A8F0-B4DA800E90DF

Q33383955-7E4C942D-B40C-413B-9701-021FCE715572

Q33383955-871542A3-A95F-4287-A028-9A8771196650

Q33383955-D10D1099-A723-46DF-852E-C18A2338F206

P577

Q33383955-D3AB7EFD-33DE-41BC-90E3-C32F1203DE88

P5875

Q33383955-E692EDD4-CC82-4952-89C0-6B7AA31DA490

P6179

Q33383955-5A0551E3-A904-4DCA-9817-47A1B8379D0F

P698

Q33383955-7964C663-EAED-4296-BF05-77F732512E8E

P932

Q33383955-6BD648CE-40D6-4B06-878F-EF5BA0E87F9D

P356

S10616-004-5127-Z

P1433

P1476

Targeting human telomerase for cancer therapeutics

@en

P2093

Chafke Belmokhtar

http://www.w3.org/2001/XMLSchema#string

Chantal Trentesaux

http://www.w3.org/2001/XMLSchema#string

Dennis Gomez

http://www.w3.org/2001/XMLSchema#string

Eliane Mandine

http://www.w3.org/2001/XMLSchema#string

Hamid Morjani

http://www.w3.org/2001/XMLSchema#string

Lionel Guittat

http://www.w3.org/2001/XMLSchema#string

Patrick Mailliet

http://www.w3.org/2001/XMLSchema#string

Rajaa Paterski

http://www.w3.org/2001/XMLSchema#string

Thibault Lemarteleur

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of parallel quadruplexes from human telomeric DNA

The Hallmarks of Cancer

ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

Extension of life-span by introduction of telomerase into normal human cells

Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates

Telomere elongation in immortal human cells without detectable telomerase activity

Telomere shortening and apoptosis in telomerase-inhibited human tumor cells

Long-term cultivation of colorectal carcinoma cells with anti-cancer drugs induces drug resistance and telomere elongation: an in vitro study

Structure of a G-quadruplex-ligand complex

P2888

s10616-004-5127-z

P304

75-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10616-004-5127-Z

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Louis Mergny

Jean-François Riou

Patrizia Alberti

Laurent Lacroix

Francois Boussin

Gaelle Pennarun

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23467692

http://www.w3.org/2001/XMLSchema#string

P6179

1033172220

http://www.w3.org/2001/XMLSchema#string

P698

19003245

http://www.w3.org/2001/XMLSchema#string

P932

3449961

http://www.w3.org/2001/XMLSchema#string